175 related articles for article (PubMed ID: 23404343)
1. Anorectal gastrointestinal stromal tumors: a retrospective multicenter analysis of 15 cases emphasizing their high local recurrence rate and the need for standardized therapeutic approach.
Agaimy A; Vassos N; Märkl B; Meidenbauer N; Köhler J; Spatz J; Hohenberger W; Haller F; Croner RS; Schneider-Stock R; Matzel K
Int J Colorectal Dis; 2013 Aug; 28(8):1057-64. PubMed ID: 23404343
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal stromal tumor of the rectum: results of surgical and multimodality therapy in the era of imatinib.
Jakob J; Mussi C; Ronellenfitsch U; Wardelmann E; Negri T; Gronchi A; Hohenberger P
Ann Surg Oncol; 2013 Feb; 20(2):586-92. PubMed ID: 22965573
[TBL] [Abstract][Full Text] [Related]
3. Local excision with adjuvant imatinib therapy for anorectal gastrointestinal stromal tumors.
Centonze D; Pulvirenti E; Pulvirenti D'Urso A; Franco S; Cinardi N; Giannone G
Tech Coloproctol; 2013 Oct; 17(5):571-4. PubMed ID: 23361497
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal stromal tumor presenting as a rectovaginal mass. Clinicopathologic and molecular-genetic characterization of a rare tumor with a literature review.
Pelz AF; Agaimy A; Daniels M; Evert M; Schulz HU; Lüders P; Müller G; Lasota J; Röpke A; Wieacker P; Miettinen M; Schneider-Stock R
Hum Pathol; 2011 Apr; 42(4):586-93. PubMed ID: 21237497
[TBL] [Abstract][Full Text] [Related]
5. [Clinicopathological analysis of 61 patients with rectal gastrointestinal stromal tumors].
Wu X; Jiang W; Zhang R; Ding P; Chen G; Lu Z; Li L; Fang Y; Wang F; Kong L; Lin J; Pan Z; Wan D
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Apr; 17(4):335-9. PubMed ID: 24760640
[TBL] [Abstract][Full Text] [Related]
6. [Clinicopathological features and prognosis of gastrointestinal stromal tumors with
Shen YY; Li XQ; Yang LX; Fang Y; Nie MM; He ZR; Hou YY; Cao H; Wang M; Shen KT
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):804-813. PubMed ID: 34530562
[No Abstract] [Full Text] [Related]
7. Microscopically positive margins for primary gastrointestinal stromal tumors: analysis of risk factors and tumor recurrence.
McCarter MD; Antonescu CR; Ballman KV; Maki RG; Pisters PW; Demetri GD; Blanke CD; von Mehren M; Brennan MF; McCall L; Ota DM; DeMatteo RP;
J Am Coll Surg; 2012 Jul; 215(1):53-9; discussion 59-60. PubMed ID: 22726733
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience.
Rutkowski P; Gronchi A; Hohenberger P; Bonvalot S; Schöffski P; Bauer S; Fumagalli E; Nyckowski P; Nguyen BP; Kerst JM; Fiore M; Bylina E; Hoiczyk M; Cats A; Casali PG; Le Cesne A; Treckmann J; Stoeckle E; de Wilt JH; Sleijfer S; Tielen R; van der Graaf W; Verhoef C; van Coevorden F
Ann Surg Oncol; 2013 Sep; 20(9):2937-43. PubMed ID: 23760587
[TBL] [Abstract][Full Text] [Related]
9. Treatment strategy of rectal gastrointestinal stromal tumor (GIST).
Liu H; Yan Z; Liao G; Yin H
J Surg Oncol; 2014 Jun; 109(7):708-13. PubMed ID: 24510506
[TBL] [Abstract][Full Text] [Related]
10. Surgical intervention for imatinib and sunitinib-resistant gastrointestinal stromal tumors.
Kikuchi H; Setoguchi T; Miyazaki S; Yamamoto M; Ohta M; Kamiya K; Sakaguchi T; Konno H
Int J Clin Oncol; 2011 Dec; 16(6):741-5. PubMed ID: 21394667
[TBL] [Abstract][Full Text] [Related]
11. The role of surgical resection following imatinib treatment in patients with recurrent or metastatic gastrointestinal stromal tumors: results of propensity score analyses.
Park SJ; Ryu MH; Ryoo BY; Park YS; Sohn BS; Kim HJ; Kim CW; Kim KH; Yu CS; Yook JH; Kim BS; Kang YK
Ann Surg Oncol; 2014 Dec; 21(13):4211-7. PubMed ID: 24980089
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine-kinase mutations in c-KIT and PDGFR-alpha genes of imatinib naïve adult patients with gastrointestinal stromal tumours (GISTs) of the stomach and small intestine: relation to tumour-biological risk-profile and long-term outcome.
Søreide K; Sandvik OM; Søreide JA; Gudlaugsson E; Mangseth K; Haugland HK
Clin Transl Oncol; 2012 Aug; 14(8):619-29. PubMed ID: 22855146
[TBL] [Abstract][Full Text] [Related]
13. Transanal endoscopic microsurgery following treatment with imatinib : a case report of a patient with a rectal gastrointestinal stromal tumor.
Tielen R; Bremers AJ; van der Graaf WT; Flucke UE; de Wilt JH
Acta Chir Belg; 2015; 115(2):166-9. PubMed ID: 26021953
[TBL] [Abstract][Full Text] [Related]
14. A long-term follow-up of the imatinib mesylate treatment for the patients with recurrent gastrointestinal stromal tumor (GIST): the liver metastasis and the outcome.
Zhu J; Yang Y; Zhou L; Jiang M; Hou M
BMC Cancer; 2010 May; 10():199. PubMed ID: 20465813
[TBL] [Abstract][Full Text] [Related]
15. Feasibility and Timing of Cytoreduction Surgery in Advanced (Metastatic or Recurrent) Gastrointestinal Stromal Tumors During the Era of Imatinib.
Chang SC; Liao CH; Wang SY; Tsai CY; Chiang KC; Cheng CT; Yeh TS; Chen YY; Ma MC; Liu CT; Yeh CN
Medicine (Baltimore); 2015 Jun; 94(24):e1014. PubMed ID: 26091448
[TBL] [Abstract][Full Text] [Related]
16. Rectal Gastrointestinal Stromal Tumor (GIST) in the Era of Imatinib: Organ Preservation and Improved Oncologic Outcome.
Cavnar MJ; Wang L; Balachandran VP; Antonescu CR; Tap WD; Keohan M; Singer S; Temple L; Nash GM; Weiser MR; Guillem JG; Aguilar JG; DeMatteo RP; Paty PB
Ann Surg Oncol; 2017 Dec; 24(13):3972-3980. PubMed ID: 29058144
[TBL] [Abstract][Full Text] [Related]
17. Primary localized rectal/pararectal gastrointestinal stromal tumors: results of surgical and multimodal therapy from the French Sarcoma group.
Huynh TK; Meeus P; Cassier P; Bouché O; Lardière-Deguelte S; Adenis A; André T; Mancini J; Collard O; Montemurro M; Bompas E; Rios M; Isambert N; Cupissol D; Blay JY; Duffaud F
BMC Cancer; 2014 Mar; 14():156. PubMed ID: 24597959
[TBL] [Abstract][Full Text] [Related]
18. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal stromal tumors in children and young adults: a clinicopathologic, molecular, and genomic study of 15 cases and review of the literature.
Prakash S; Sarran L; Socci N; DeMatteo RP; Eisenstat J; Greco AM; Maki RG; Wexler LH; LaQuaglia MP; Besmer P; Antonescu CR
J Pediatr Hematol Oncol; 2005 Apr; 27(4):179-87. PubMed ID: 15838387
[TBL] [Abstract][Full Text] [Related]
20. Preoperative Chemotherapy and Survival for Large Anorectal Gastrointestinal Stromal Tumors: A National Analysis of 333 Cases.
Hawkins AT; Wells KO; Krishnamurty DM; Hunt SR; Mutch MG; Glasgow SC; Wise PE; Silviera ML
Ann Surg Oncol; 2017 May; 24(5):1195-1201. PubMed ID: 28050726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
